EP 2827852 A4 20160302 - EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF

Title (en)

EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF

Title (de)

FORMULIERUNG MIT VERLÄNGERTER FREISETZUNG ZUR VERRINGERUNG DER BLASENENTLEERUNGSHÄUFIGKEIT UND VERFAHREN ZUR VERWENDUNG DAVON

Title (fr)

FORMULATION À LIBÉRATION PROLONGÉE POUR RÉDUIRE LA FRÉQUENCE DE MICTION ET SON PROCÉDÉ D'UTILISATION

Publication

EP 2827852 A4 20160302 (EN)

Application

EP 13763764 A 20130313

Priority

US 201213424000 A 20120319
US 201213487348 A 20120604
US 2013030901 W 20130313

Abstract (en)

[origin: WO2013142197A1] Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising an analgesic agent formulated in an extended-release formulation. Another method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising multiple active ingredients formulated for extended-release.

IPC 8 full level

A61K 31/12 (2006.01); A61K 9/00 (2006.01); A61K 31/167 (2006.01); A61K 31/192 (2006.01); A61K 31/405 (2006.01); A61K 31/616 (2006.01); A61K 45/06 (2006.01); A61P 7/12 (2006.01); A61P 13/10 (2006.01)

CPC (source: CN EP KR RU)

A61K 9/0002 (2013.01 - KR); A61K 31/12 (2013.01 - CN); A61K 31/122 (2013.01 - CN EP KR); A61K 31/167 (2013.01 - CN EP KR); A61K 31/18 (2013.01 - CN); A61K 31/192 (2013.01 - CN EP KR RU); A61K 31/405 (2013.01 - CN); A61K 31/437 (2013.01 - CN EP KR); A61K 31/4375 (2013.01 - RU); A61K 31/438 (2013.01 - RU); A61K 31/4985 (2013.01 - RU); A61K 31/58 (2013.01 - CN); A61K 31/616 (2013.01 - CN EP KR); A61K 45/06 (2013.01 - CN); A61P 7/00 (2018.01 - EP); A61P 7/10 (2018.01 - EP KR); A61P 7/12 (2018.01 - EP KR); A61P 13/00 (2018.01 - EP); A61P 13/02 (2018.01 - EP KR); A61P 13/06 (2018.01 - KR); A61P 13/10 (2018.01 - EP KR RU); A61P 43/00 (2018.01 - EP)

C-Set (source: CN EP)

Citation (search report)

[Y] WO 03070233 A1 20030828 - PHARMACIA CORP [US], et al
[Y] US 2004054008 A1 20040318 - ARAKI TOHRU [JP]
[Y] WO 2011107755 A2 20110909 - UNIV STRATHCLYDE [GB], et al
[Y] WO 2010138441 A1 20101202 - APTAPHARMA INC [US], et al
[Y] US 2008085314 A1 20080410 - SHALABY SHALABY W [US]
[Y] WO 0119350 A1 20010322 - COPLEY PHARMACEUTICAL INC [US], et al
[Y] EP 1627876 A1 20060222 - FERRING BV [NL]
[Y] US 2004198822 A1 20041007 - FRASER MATTHEW OLIVER [US], et al
[A] EP 1053752 A1 20001122 - YOSHITOMI PHARMACEUTICAL [JP]
[Y] US 2012010294 A1 20120112 - DILL DAVID A [US]
[Y] PINNA C ET AL: "Altered neurogenic and mechanical responses to acetylcholine, ATP and substance P in detrusor from rat with outlet obstruction", LIFE SCIENCES, PERGAMON PRESS, OXFORD, GB, vol. 79, no. 13, 22 August 2006 (2006-08-22), pages 1301 - 1306, XP028051173, ISSN: 0024-3205, [retrieved on 20060822], DOI: 10.1016/J.LFS.2006.03.035
[Y] ADDLA S K ET AL: "Diclofenac for Treatment of Nocturia Caused by Nocturnal Polyuria: A Prospective, Randomised, Double-Blind, Placebo-Controlled Crossover Study", EUROPEAN UROLOGY, ELSEVIER BV, NL, vol. 49, no. 4, 1 April 2006 (2006-04-01), pages 720 - 726, XP027881854, ISSN: 0302-2838, [retrieved on 20060401]
[Y] WEIN A J ET AL: "Overactive Bladder: A Better Understanding of Pathophysiology, Diagnosis and Management", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, vol. 175, no. 3, 1 March 2006 (2006-03-01), pages S5 - S10, XP024989968, ISSN: 0022-5347, [retrieved on 20060301], DOI: 10.1016/S0022-5347(05)00313-7
[Y] WEISS ET AL: "NOCTURIA", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, vol. 163, no. 1, 1 January 2000 (2000-01-01), pages 5 - 12, XP005556162, ISSN: 0022-5347, DOI: 10.1016/S0022-5347(05)67961-X
[Y] MATTHIESEN ET AL: "Nocturnal Polyuria and Natriuresis in Male Patients with Nocturia and Lower Urinary Tract Symptoms", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, vol. 156, no. 4, 1 October 1996 (1996-10-01), pages 1292 - 1299, XP005573755, ISSN: 0022-5347, DOI: 10.1016/S0022-5347(01)65572-1
[Y] KOUSEI MIWA, YOSHINORI NISHINO, MINA KIKUCHI, TAKAKO MASUE, YOJI MORIYAMA, TAKASHI DEGUCHI: "Efficacy of combination therapy with tamsulosin and zolpidem on nocturia in patients with benign prostatic hyperplasia", CENTRAL EUROPEAN JOURNAL OF UROLOGY, vol. 4, 30 April 2011 (2011-04-30), pages 232 - 235, XP002743173, ISSN: 2080-4806
[Y] YOKOYAMA, O., MATSUTA, Y., YANAI-INAMURA, H., WATANABE, M., OHTAKE, A., SUZUKI, M. AND SASAMATA, M.: "Zolpidem increases bladder capacity and decreases urine excretion in rats", NEUROUROLOGY AND URODYNAMICS, vol. 29, no. 4, 30 April 2010 (2010-04-30), pages 587 - 591, XP002743174, DOI: 10.1002/nau.20797
See also references of WO 2013142197A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2013142197 A1 20130926; AU 2013235507 A1 20140821; AU 2013235507 B2 20170323; AU 2013235518 A1 20140925; AU 2013235518 A2 20141009; AU 2013235518 B2 20170302; AU 2017203139 A1 20170601; AU 2017203139 B2 20180719; AU 2017203246 A1 20170608; AU 2017203246 B2 20181018; BR 112014020113 A2 20170620; BR 112014020113 A8 20170711; BR 112014020271 A2 20170620; BR 112014020271 A8 20170711; CA 2866755 A1 20130926; CA 2866853 A1 20130726; CN 104302284 A 20150121; CN 104321056 A 20150128; CN 107157991 A 20170915; CN 107789626 A 20180313; EP 2827851 A1 20150128; EP 2827851 A4 20151014; EP 2827852 A1 20150128; EP 2827852 A4 20160302; HK 1204553 A1 20151127; HK 1243921 A1 20180727; HK 1251469 A1 20190201; JP 2015510928 A 20150413; JP 2015510936 A 20150413; JP 2016172752 A 20160929; JP 2018024693 A 20180215; JP 2018138602 A 20180906; KR 20140134284 A 20141121; KR 20140134333 A 20141121; KR 20170015537 A 20170208; KR 20190003840 A 20190109; MX 2014011128 A 20150810; MX 2014011129 A 20150810; MX 2019008817 A 20190926; MY 174090 A 20200309; MY 175764 A 20200708; NZ 628079 A 20160527; NZ 630471 A 20160429; NZ 712594 A 20160930; NZ 714288 A 20161223; NZ 714662 A 20160826; NZ 718163 A 20170929; RU 2014142025 A 20160510; RU 2014142066 A 20160510; RU 2016133305 A 20181210; RU 2016133305 A3 20181210; RU 2599017 C2 20161010; RU 2669565 C2 20181012; SG 11201500408V A 20150330; SG 11201500409S A 20150330; WO 2013142274 A1 20130926; ZA 201405862 B 20160831; ZA 201406146 B 20160831

DOCDB simple family (application)

US 2013030901 W 20130313; AU 2013235507 A 20130314; AU 2013235518 A 20130313; AU 2017203139 A 20170511; AU 2017203246 A 20170515; BR 112014020113 A 20130314; BR 112014020271 A 20130313; CA 2866755 A 20130314; CA 2866853 A 20130313; CN 201380015025 A 20130314; CN 201380015062 A 20130313; CN 201710373440 A 20130313; CN 201711086139 A 20130314; EP 13763665 A 20130314; EP 13763764 A 20130313; HK 15105034 A 20150527; HK 18103371 A 20180310; HK 18110965 A 20150527; JP 2015501754 A 20130313; JP 2015501785 A 20130314; JP 2016092868 A 20160504; JP 2017179685 A 20170920; JP 2018093416 A 20180515; KR 20147024604 A 20130314; KR 20147029163 A 20130313; KR 20177002422 A 20130314; KR 20187038194 A 20130314; MX 2014011128 A 20130313; MX 2014011129 A 20130314; MX 2019008817 A 20140917; MY PI2014702174 A 20130314; MY PI2014702434 A 20130313; NZ 62807913 A 20130314; NZ 63047113 A 20130313; NZ 71259413 A 20130313; NZ 71428813 A 20130313; NZ 71466213 A 20130314; NZ 71816313 A 20130313; RU 2014142025 A 20130313; RU 2014142066 A 20130314; RU 2016133305 A 20130314; SG 11201500408V A 20130313; SG 11201500409S A 20130314; US 2013031617 W 20130314; ZA 201405862 A 20140811; ZA 201406146 A 20140821